NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective efficacy of a SARS-CoV-2 subunit vaccine (NVX-CoV2373) produced from the full-length SARS-CoV-2 spike (S) glycoprotein stabiliz...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15621

Acceso en línea:

https://doi.org/10.1016/j.vaccine.2020.10.064
http://hdl.handle.net/20.500.12010/15621

Palabra clave:

SARS-CoV-2
COVID-19
Spike glycoprotein
NVX-CoV2373 nanoparticles
Matrix-M adjuvant
Nonhuman primate
COVID-19 (Enfermedad)
Infecciones por coronavirus
Vacunas - Pruebas

Rights

License

Abierto (Texto Completo)